Endoscopic Transsphenoidal Surgery of Microprolactinomas: A Reappraisal of Cure Rate Based on Radiological Criteria

Abstract Background Current standard treatment of microprolactinomas is dopamine agonist therapy. As this drug treatment is lifelong in up to 80% of cases, many patients consult pituitary surgeons regarding a surgical alternative. Objective To identify prognostic criteria for surgical remission, we...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Neurosurgery Jg. 85; H. 4; S. 508 - 515
Hauptverfasser:	Micko, Alexander, Vila, Greisa, Höftberger, Romana, Knosp, Engelbert, Wolfsberger, Stefan
Format:	Journal Article
Sprache:	Englisch
Veröffentlicht:	United States Oxford University Press 01.10.2019 Copyright by the Congress of Neurological Surgeons Wolters Kluwer Health, Inc
Schlagworte:	Adult Aged Agonists Cabergoline Cohort Studies Endoscopy Female Humans Logistic Models Magnetic Resonance Imaging - methods Male Middle Aged Neuroendoscopy - methods Neurosurgery Pituitary gland Pituitary Neoplasms - diagnostic imaging Pituitary Neoplasms - pathology Pituitary Neoplasms - surgery Prognosis Prolactin Prolactinoma - diagnostic imaging Prolactinoma - pathology Prolactinoma - surgery Surgeons Surgery Treatment Outcome Tumors Young Adult Austria Endoscopic surgery Medial cavernous sinus wall Microprolactinoma Dopamin agonist treatment
ISSN:	0148-396X, 1524-4040, 1524-4040
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!